Evidence-based pharmaceutical options for managing canine noise phobia welfare, covering acute and preventive medications, administration timing, and how drugs integrate with behavioral treatment.
Pharmaceutical management of canine noise phobia provides an important welfare tool that complements behavioral treatment. The old view that medication was a last resort or indicated weakness has been replaced by evidence-based recognition that phobia often involves neurobiological states that behavioral modification alone cannot adequately address. Appropriate medication reduces the intensity of fear responses during acute events, prevents the cortisol elevation that causes hours of welfare compromise after noise events appear to have passed, and creates the reduced arousal state in which behavioral modification can be more effective. The key pharmaceutical principles for noise phobia are: choose drugs that reduce anxiety (not just cause sedation), administer before the trigger when possible, and use medication as part of a comprehensive welfare plan.